Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2013 085 648.6 |
96 | EP file number | EAKZ | 21 16 7811.5 |
97 | EP publication number | EPN | 3889181 |
54 | Designation/title | TI | EIN IL-4R-ANTAGONISTISCHER ANTIKÖRPER ZUR VERWENDUNG IN DER BEHANDLUNG ATOPISCHER DERMATITIS |
51 | IPC main class | ICM (ICMV) | C07K 16/28 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | G01N 33/53 (2006.01), A61P 17/00 (2006.01) |
22 | DE application date | DAT | Sep 4, 2013 |
96 | EP application date | EAT | Sep 4, 2013 |
43 | Date of first publication | OT | Oct 6, 2021 |
| Date of publication of grant | PET | Apr 24, 2024 |
71/73 | Applicant/owner | INH | Regeneron Pharmaceuticals, Inc., Tarrytown, NY, US; Sanofi Biotechnology, Paris, FR |
72 | Inventor | IN | ARDELEANU, Marius, New York, 10605, US; GRAHAM, Neil, New York, 10520, US; HAMILTON, Jennifer D, New York, 12533, US; KIRKESSELI, Stephane C, 75008 Paris, FR; KUNDU, Sudeep, New York, 10022, US; MING, Jeffrey, New Jersey, 08807, US; RADIN, Allen, New York, 10128, US; ROCKLIN, Ross E, New Jersey, 07920, US; WEINSTEIN, Steven P, New York, 10530, US |
| Address for service | | JAK France, 47000 Agen, FR |
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261738715 P Dec 18, 2012
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| FR 1356759 Jul 10, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361748588 P Jan 3, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361768229 P Feb 22, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361782420 P Mar 14, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361816191 P Apr 26, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361770091 P Feb 27, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201361764624 P Feb 14, 2013
|
33 31 32
| Foreign priority | PRC PRNA PRDA
| US 201261697972 P Sep 7, 2012
|
| Due date | FT FG | Sep 30, 2025 Annual fee for the 13th year
Patent fees |
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
84 | Designated EP contracting states | EDS | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000003889181A1 Searchable text:
EP000003889181A1 Original document:
EP000003889181B1 Searchable text:
EP000003889181B1 |
43 | Date of first publication | EVT | Oct 6, 2021 |
| Date of the first transfer into DPMAregister | EREGT | Oct 6, 2021 |
| Date of the (most recent) update in DPMAregister | REGT | Mar 13, 2025 (Show all update days)(Hide all update days)- Mar 13, 2025
- Procedures: Opposition procedure, Opposition filed, 23.01.2025: changed
- Feb 13, 2025
- Procedures: Opposition procedure, Opposition filed, 23.01.2025: new
- Feb 6, 2025
- St.36: changed (technical change)
- Jan 30, 2025
- St.36: changed (technical change)
- Nov 14, 2024
- St.36: changed (technical change)
- Oct 31, 2024
- St.36: changed (technical change)
- Aug 28, 2024
- May 8, 2024; Apr 5, 2024; Apr 4, 2024; Dec 7, 2023
- Historical data not available for this/these date(s)
- Oct 6, 2021
- Date of the first transfer into DPMAregister
|